<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00427193</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00016876</org_study_id>
    <secondary_id>PBRC U01-AG0204878</secondary_id>
    <secondary_id>Tufts U01-AG020480</secondary_id>
    <secondary_id>WashU U01-AG020487</secondary_id>
    <secondary_id>DCRI/Duke U01-AG022132</secondary_id>
    <secondary_id>AG0078</secondary_id>
    <nct_id>NCT00427193</nct_id>
  </id_info>
  <brief_title>CALERIE: Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy</brief_title>
  <official_title>Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy (CALERIE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the hypothesis that two years of sustained 25% caloric
      restriction (CR) in men age 21-50 (inclusive) and women age 21-47 (inclusive) will slow aging
      and protect against age-related disease processes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The overall aim of CALERIE Phase 2 is to test the hypothesis that two years of sustained
      caloric restriction (CR), involving a reduction in energy intake to 75% of baseline (25% CR),
      in healthy, non-obese men aged 21-50 (inclusive) and women aged 21-47 (inclusive), will
      result in the same adaptive changes that were observed in a wide variety of animal studies.
      Particular emphasis is on the adaptive responses thought to be involved in slowing the aging
      process and protecting against age-related disease processes. Primary outcomes include core
      body temperature and resting metabolic rate. Secondary outcomes include risk factors for
      cardiovascular disease, inflammatory markers, immune function, psychological and physical
      function; oxidative changes in lipids, proteins, and DNA; and, risk factors for age-related
      conditions such as diabetes and body composition. An important secondary aim is to identify
      potential adverse effects of CR in humans.

      The study will be conducted as a multi-center, parallel-group, randomized, controlled trial
      (RCT). A sample of 200 participants will be enrolled, and assigned to either the CR
      intervention or a control group. Control participants will be advised to simply continue
      their current diets. Participants in both treatment arms will be followed over a period of 24
      months. A comprehensive set of evaluations will be performed prior to initiating the
      intervention, with follow-up evaluations at 1, 3, 6, 9, 12, 18 and 24 months afterwards.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>all lab based assays were masked due to de-identified person and time interval measured. All physical measures were masked to intervention group status.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Core Body Temperature, Baseline to 12 Months</measure>
    <time_frame>Baseline to 12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Core Temperature, Baseline to 24 Months</measure>
    <time_frame>Baseline to 24 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Resting Metabolic Rate (RMR) Corrected for Changes in Body Composition, Baseline to 12 Months</measure>
    <time_frame>Baseline, 12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Resting Metabolic Rate (RMR) Corrected for Changes in Body Composition</measure>
    <time_frame>Baseline, 24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Tumor Necrosis Factor-α (TNF-α), Baseline to 12 Months</measure>
    <time_frame>change baseline to 12 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in Fat Mass</measure>
    <time_frame>change 0 to 24 months</time_frame>
    <description>Difference in change in Fat Mass between prescribed 25% Caloric Restriction (CR) and Ad Libitum (AL) at 12 and 24 months as measured by dual X-ray absorptiometry (DXA) using the Hologic 4500A, Delphi W or Discovery A, by a standardized protocol according to a standardized protocol. Fat Mass (FM) was determined for the whole body.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Fat Mass</measure>
    <time_frame>baseline, 12 months</time_frame>
    <description>Difference in change in Fat Mass between prescribed 25% Caloric Restriction (CR) and Ad Libitum (AL) at 12 and 24 months as measured by dual X-ray absorptiometry (DXA) using the Hologic 4500A, Delphi W or Discovery A, by a standardized protocol according to a standardized protocol. Fat Mass (FM) was determined for the whole body.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">238</enrollment>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>Caloric Restriction (CR)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>25% caloric restriction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control, Ad libitum (AL)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ad libitum energy intake</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Caloric Restriction (CR)</intervention_name>
    <description>Participants follow a diet with 25% fewer calories than calculated at baseline over a period of 24 months</description>
    <arm_group_label>Caloric Restriction (CR)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Participants continue their current diet for 24 months</description>
    <arm_group_label>Control, Ad libitum (AL)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age must be between 21-50 (inclusive) for men and 21-47 (inclusive) for women

          -  Body mass index (BMI) must be greater than or equal to 22 and less than 28

          -  Female participants must use acceptable forms of contraception (barrier method, oral
             contraceptive, intra-uterine device, or similar) and be willing to continue using such
             a method while enrolled in the study

        Exclusion Criteria:

          -  History or clinical manifestation of cardiovascular disease or an elevated blood
             pressure (greater than 140/90 mm Hg)

          -  Abnormal resting ECG

          -  History or clinical manifestation of diabetes

          -  History or clinical manifestation of cholelithiasis (the presence or formation of
             gallstones in the gallbladder or bile ducts)

          -  History of anaphylaxis, severe allergies, or asthma

          -  History or clinical manifestation of any other significant metabolic, hematologic,
             pulmonary, cardiovascular, gastrointestinal, neurologic, immune, hepatic, renal,
             urologic disorders, or cancer that, in opinion of the investigator, would make the
             candidate ineligible for the study

          -  History of stomach or intestinal surgery (except appendectomy) or major abdominal,
             thoracic or non-peripheral vascular surgery within one year prior to the randomization
             date

          -  Any disease or condition that seriously affects body weight and/or body composition

          -  Potassium level above the upper limit of normal at the screening visit confirmed by a
             test repeated within two weeks

          -  Hemoglobin, hematocrit, RBC, or iron level below the lower limit of normal at the
             screening visit confirmed by a test repeated within two weeks

          -  Evidence of active liver disease or ALT levels above 1.5 times the upper limit of
             normal

          -  Practice a vegan dietary lifestyle

          -  History or clinical manifestation of any eating disorder

          -  Any history of pharmacologic treatment for a psychiatric disorder within one year
             prior to the randomization date or a history of more than one episode of a
             pharmacologic treatment for a psychiatric disorder within lifetime

          -  History of drug or alcohol abuse (up to 14 drinks a week are allowed) within the past
             two years

          -  BDI (Beck Depression Inventory) score of 20 or higher at screening or baseline

          -  Treatment with steroids for more than a month within five years prior to the
             randomization date, or short-term (less than a month) treatment with steroids within
             six months prior to the randomization date

          -  Regular use of other medications, except contraceptives

          -  Participated in the CALERIE Phase 1 studies

          -  Lost or gained 3 kg or more over the past six months

          -  A volunteer must be either a never-smoker of tobacco products or an ex-smoker who quit
             completely at least 12 months prior to the screening visit

          -  Donated blood within 30 days prior to the randomization date

          -  Concurrent participation in any other interventional study

          -  Breast-feeding or pregnant women or women intending to become pregnant before the
             scheduled end of the intervention

          -  Engaged in a regular program of physical fitness involving some kind of heavy physical
             activity (e.g., jogging, running or riding fast on a bicycle for 30 minutes or more)
             five or more times per week over the past year

          -  Unwilling to be assigned at random to the CR or control intervention

          -  Unwilling or unable to adhere to the rigors of the CR intervention over the entire
             two-year intervention period

          -  Unable or unwilling to discontinue dietary supplements or adhere to the alcohol
             consumption restrictions during the study

          -  Unwilling or unable to adhere to the rigors of the data collection and clinical
             evaluation schedule over the entire two-year period follow-up period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William Kraus, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke Clinical Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pennington Biomedical Research Center</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jean Mayer Human Nutrition Research Center on Aging at Tufts University</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Ravussin E, Redman LM, Rochon J, Das SK, Fontana L, Kraus WE, Romashkan S, Williamson DA, Meydani SN, Villareal DT, Smith SR, Stein RI, Scott TM, Stewart TM, Saltzman E, Klein S, Bhapkar M, Martin CK, Gilhooly CH, Holloszy JO, Hadley EC, Roberts SB; CALERIE Study Group. A 2-Year Randomized Controlled Trial of Human Caloric Restriction: Feasibility and Effects on Predictors of Health Span and Longevity. J Gerontol A Biol Sci Med Sci. 2015 Sep;70(9):1097-104. doi: 10.1093/gerona/glv057. Epub 2015 Jul 17. Erratum in: J Gerontol A Biol Sci Med Sci. 2016 Jun;71(6):839-40.</citation>
    <PMID>26187233</PMID>
  </results_reference>
  <results_reference>
    <citation>Rochon J, Bales CW, Ravussin E, Redman LM, Holloszy JO, Racette SB, Roberts SB, Das SK, Romashkan S, Galan KM, Hadley EC, Kraus WE; CALERIE Study Group. Design and conduct of the CALERIE study: comprehensive assessment of the long-term effects of reducing intake of energy. J Gerontol A Biol Sci Med Sci. 2011 Jan;66(1):97-108. doi: 10.1093/gerona/glq168. Epub 2010 Oct 5.</citation>
    <PMID>20923909</PMID>
  </results_reference>
  <results_reference>
    <citation>Racette SB, Rochon J, Uhrich ML, Villareal DT, DAS SK, Fontana L, Bhapkar M, Martin CK, Redman LM, Fuss PJ, Roberts SB, Kraus WE. Effects of Two Years of Calorie Restriction on Aerobic Capacity and Muscle Strength. Med Sci Sports Exerc. 2017 Nov;49(11):2240-2249. doi: 10.1249/MSS.0000000000001353.</citation>
    <PMID>29045325</PMID>
  </results_reference>
  <results_reference>
    <citation>Belsky DW, Huffman KM, Pieper CF, Shalev I, Kraus WE. Change in the Rate of Biological Aging in Response to Caloric Restriction: CALERIE Biobank Analysis. J Gerontol A Biol Sci Med Sci. 2017 Dec 12;73(1):4-10. doi: 10.1093/gerona/glx096.</citation>
    <PMID>28531269</PMID>
  </results_reference>
  <results_reference>
    <citation>Martin CK, Bhapkar M, Pittas AG, Pieper CF, Das SK, Williamson DA, Scott T, Redman LM, Stein R, Gilhooly CH, Stewart T, Robinson L, Roberts SB; Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE) Phase 2 Study Group. Effect of Calorie Restriction on Mood, Quality of Life, Sleep, and Sexual Function in Healthy Nonobese Adults: The CALERIE 2 Randomized Clinical Trial. JAMA Intern Med. 2016 Jun 1;176(6):743-52. doi: 10.1001/jamainternmed.2016.1189.</citation>
    <PMID>27136347</PMID>
  </results_reference>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>January 24, 2007</study_first_submitted>
  <study_first_submitted_qc>January 25, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2007</study_first_posted>
  <results_first_submitted>April 25, 2018</results_first_submitted>
  <results_first_submitted_qc>December 4, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">December 6, 2018</results_first_posted>
  <last_update_submitted>December 4, 2018</last_update_submitted>
  <last_update_submitted_qc>December 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dietary restriction</keyword>
  <keyword>disease /disorder prevention /control</keyword>
  <keyword>nutrition of aging</keyword>
  <keyword>bioenergetics</keyword>
  <keyword>cardiovascular function</keyword>
  <keyword>disease /disorder proneness /risk</keyword>
  <keyword>insulin sensitivity / resistance</keyword>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>238 Participants were eligible, 18 participants withdrew prior to randomization, 220 participants were randomized to the study, and 2 participants withdrew prior to initiating the intervention.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Caloric Restriction (CR)</title>
          <description>25% caloric restriction
Caloric Restriction (CR): Participants follow a diet with 25% fewer calories than calculated at baseline over a period of 24 months</description>
        </group>
        <group group_id="P2">
          <title>Ad Libitum</title>
          <description>Ad libitum energy intake
Control: Participants continue their current diet for 24 months</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="143"/>
                <participants group_id="P2" count="75"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="117"/>
                <participants group_id="P2" count="71"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Caloric Restriction (CR)</title>
          <description>25% caloric restriction
Caloric Restriction (CR): Participants follow a diet with 25% fewer calories than calculated at baseline over a period of 24 months</description>
        </group>
        <group group_id="B2">
          <title>Ad Libitum</title>
          <description>Ad libitum energy intake
Control: Participants continue their current diet for 24 months</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="143"/>
            <count group_id="B2" value="75"/>
            <count group_id="B3" value="218"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.2" spread="7.3"/>
                    <measurement group_id="B2" value="38.1" spread="6.9"/>
                    <measurement group_id="B3" value="38.1" spread="7.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="99"/>
                    <measurement group_id="B2" value="53"/>
                    <measurement group_id="B3" value="152"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="111"/>
                    <measurement group_id="B2" value="57"/>
                    <measurement group_id="B3" value="168"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>African-American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Core Body Temperature, Baseline to 12 Months</title>
        <time_frame>Baseline to 12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Caloric Restriction (CR)</title>
            <description>25% caloric restriction
Caloric Restriction (CR): Participants follow a diet with 25% fewer calories than calculated at baseline over a period of 24 months</description>
          </group>
          <group group_id="O2">
            <title>Ad Libitum</title>
            <description>Ad libitum energy intake
Control: Participants continue their current diet for 24 months</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Core Body Temperature, Baseline to 12 Months</title>
          <units>degrees Celsius</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="0.02"/>
                    <measurement group_id="O2" value="-0.03" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>All analysis under intention-to-treat. All observations were included The primary analytic was a repeated measures analysis. The dependent variable was the change from baseline 12 &amp; 14mos., with treatment, time, and the treatment × time interaction as independent variables. Site, sex, BMI stratum, and the baseline value of the outcome were included as covariates. The predicted mean changes ± standard errors are the adjusted values from the contrasts of the multiple timepoints.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.70</p_value>
            <p_value_desc>Type I error was controlled using a hierarchical gatekeeping strategy.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>difference in mean change</param_type>
            <param_value>0.02</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>0.02</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.019</ci_lower_limit>
            <ci_upper_limit>0.059</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Core Temperature, Baseline to 24 Months</title>
        <time_frame>Baseline to 24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Prescribed 25% Caloric Restriction</title>
            <description>2 years of prescribed 25% Caloric Restriction</description>
          </group>
          <group group_id="O2">
            <title>Ad Libitum</title>
            <description>Usual caloric intake</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Core Temperature, Baseline to 24 Months</title>
          <units>degrees Celsius</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="0.02"/>
                    <measurement group_id="O2" value="-0.02" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.84</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.03</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.02</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.0092</ci_lower_limit>
            <ci_upper_limit>0.069</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Resting Metabolic Rate (RMR) Corrected for Changes in Body Composition, Baseline to 12 Months</title>
        <time_frame>Baseline, 12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Caloric Restriction (CR)</title>
            <description>25% caloric restriction
Caloric Restriction (CR): Participants follow a diet with 25% fewer calories than calculated at baseline over a period of 24 months</description>
          </group>
          <group group_id="O2">
            <title>Ad Libitum</title>
            <description>Ad libitum energy intake
Control: Participants continue their current diet for 24 months</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Resting Metabolic Rate (RMR) Corrected for Changes in Body Composition, Baseline to 12 Months</title>
          <units>Kcal/day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-83" spread="10"/>
                    <measurement group_id="O2" value="-1" spread="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-82</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>11.12</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-103.8</ci_lower_limit>
            <ci_upper_limit>-60.2</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Resting Metabolic Rate (RMR) Corrected for Changes in Body Composition</title>
        <time_frame>Baseline, 24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Caloric Restriction (CR)</title>
            <description>25% caloric restriction
Caloric Restriction (CR): Participants follow a diet with 25% fewer calories than calculated at baseline over a period of 24 months</description>
          </group>
          <group group_id="O2">
            <title>Ad Libitum</title>
            <description>Ad libitum energy intake
Control: Participants continue their current diet for 24 months</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Resting Metabolic Rate (RMR) Corrected for Changes in Body Composition</title>
          <units>Kcal/day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-71" spread="12"/>
                    <measurement group_id="O2" value="-7" spread="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-64</param_value>
            <dispersion_type>Standard Deviation</dispersion_type>
            <dispersion_value>13.5</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-90.5</ci_lower_limit>
            <ci_upper_limit>-37.5</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Tumor Necrosis Factor-α (TNF-α), Baseline to 12 Months</title>
        <time_frame>change baseline to 12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Caloric Restriction (CR)</title>
            <description>25% caloric restriction
Caloric Restriction (CR): Participants follow a diet with 25% fewer calories than calculated at baseline over a period of 24 months</description>
          </group>
          <group group_id="O2">
            <title>Ad Libitum</title>
            <description>Ad libitum energy intake
Control: Participants continue their current diet for 24 months</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Tumor Necrosis Factor-α (TNF-α), Baseline to 12 Months</title>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.30" spread="0.09"/>
                    <measurement group_id="O2" value="-0.34" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.82</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.04</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.10</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.16</ci_lower_limit>
            <ci_upper_limit>0.23</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Change in Fat Mass</title>
        <description>Difference in change in Fat Mass between prescribed 25% Caloric Restriction (CR) and Ad Libitum (AL) at 12 and 24 months as measured by dual X-ray absorptiometry (DXA) using the Hologic 4500A, Delphi W or Discovery A, by a standardized protocol according to a standardized protocol. Fat Mass (FM) was determined for the whole body.</description>
        <time_frame>change 0 to 24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Prescribed 25% Caloric Restriction</title>
            <description>2 years of prescribed 25% Caloric Restriction</description>
          </group>
          <group group_id="O2">
            <title>Ad Libitum</title>
            <description>Usual caloric intake</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Fat Mass</title>
          <description>Difference in change in Fat Mass between prescribed 25% Caloric Restriction (CR) and Ad Libitum (AL) at 12 and 24 months as measured by dual X-ray absorptiometry (DXA) using the Hologic 4500A, Delphi W or Discovery A, by a standardized protocol according to a standardized protocol. Fat Mass (FM) was determined for the whole body.</description>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.1" spread="0.22"/>
                    <measurement group_id="O2" value="-0.2" spread="0.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Difference in change in Fat Mass between prescribed 25% Caloric Restriction (CR) and Ad Libitum (AL) at 12 and 24 months as measured by dual X-ray absorptiometry (DXA) using the Hologic 4500A, Delphi W or Discovery A, by a standardized protocol according to a standardized protocol. Fat Mass (FM) and Fat Free Mass (FFM) were determined for the whole body.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-5.9</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.31</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-6.5</ci_lower_limit>
            <ci_upper_limit>-5.3</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Change in Fat Mass</title>
        <description>Difference in change in Fat Mass between prescribed 25% Caloric Restriction (CR) and Ad Libitum (AL) at 12 and 24 months as measured by dual X-ray absorptiometry (DXA) using the Hologic 4500A, Delphi W or Discovery A, by a standardized protocol according to a standardized protocol. Fat Mass (FM) was determined for the whole body.</description>
        <time_frame>baseline, 12 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Prescribed 25% Caloric Restriction</title>
            <description>2 years of prescribed 25% Caloric Restriction</description>
          </group>
          <group group_id="O2">
            <title>Ad Libitum</title>
            <description>Usual caloric intake</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Fat Mass</title>
          <description>Difference in change in Fat Mass between prescribed 25% Caloric Restriction (CR) and Ad Libitum (AL) at 12 and 24 months as measured by dual X-ray absorptiometry (DXA) using the Hologic 4500A, Delphi W or Discovery A, by a standardized protocol according to a standardized protocol. Fat Mass (FM) was determined for the whole body.</description>
          <units>Kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="143"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.1" spread="0.22"/>
                    <measurement group_id="O2" value="-0.3" spread="0.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison of change in FM in 2 groups over at 24 mos, controlling for site, sex, BMI group, and baseline FM. A repeated measures Mixed Model was employed for the analysis. For any outcome, Type I error was controlled using a hierarchical gatekeeping strategy testing, first, the GroupXTime interaction, and, if non-significant, the main effects of these two factors. Bonferroni corrections were employed for non-significant effects. All tests were at p&lt;0.05</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-5.9</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.26</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-6.4</ci_lower_limit>
            <ci_upper_limit>-5.3</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>0 to 24 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Caloric Restriction (CR)</title>
          <description>25% caloric restriction
Caloric Restriction (CR): Participants follow a diet with 25% fewer calories than calculated at baseline over a period of 24 months</description>
        </group>
        <group group_id="E2">
          <title>Ad Libitum</title>
          <description>Ad libitum energy intake
Control: Participants continue their current diet for 24 months</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (10.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="143"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="143"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>intestinal abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="143"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>small intestinal obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="143"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>pneumothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="143"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>scoliosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="143"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>spinal osteoarthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="143"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>spontaneous miscarriage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="143"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>leiomyoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="143"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>atrial septal defect</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="143"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA (10.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="136" subjects_at_risk="143"/>
                <counts group_id="E2" subjects_affected="72" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>anemia</sub_title>
                <counts group_id="E1" events="99" subjects_affected="35" subjects_at_risk="143"/>
                <counts group_id="E2" events="34" subjects_affected="17" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>dizziness</sub_title>
                <counts group_id="E1" events="48" subjects_affected="9" subjects_at_risk="143"/>
                <counts group_id="E2" events="14" subjects_affected="10" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>nasal congestion</sub_title>
                <counts group_id="E1" events="28" subjects_affected="19" subjects_at_risk="143"/>
                <counts group_id="E2" events="14" subjects_affected="5" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>constipation</sub_title>
                <counts group_id="E1" events="44" subjects_affected="18" subjects_at_risk="143"/>
                <counts group_id="E2" events="11" subjects_affected="5" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>toothache</sub_title>
                <counts group_id="E1" events="21" subjects_affected="6" subjects_at_risk="143"/>
                <counts group_id="E2" events="12" subjects_affected="5" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>pain</sub_title>
                <counts group_id="E1" events="20" subjects_affected="12" subjects_at_risk="143"/>
                <counts group_id="E2" events="10" subjects_affected="5" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>rash</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="143"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>gastrointestinal virus</sub_title>
                <counts group_id="E1" events="16" subjects_affected="13" subjects_at_risk="143"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>urinary tract infection</sub_title>
                <counts group_id="E1" events="11" subjects_affected="4" subjects_at_risk="143"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>diarrhea</sub_title>
                <counts group_id="E1" events="27" subjects_affected="20" subjects_at_risk="143"/>
                <counts group_id="E2" events="16" subjects_affected="10" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>muscle strain</sub_title>
                <counts group_id="E1" events="16" subjects_affected="3" subjects_at_risk="143"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>Excessive bone loss</sub_title>
                <description>by BMD at lumbar spine, total hip and intertrochanter</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="143"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>dysmenorrhea</sub_title>
                <counts group_id="E1" events="78" subjects_affected="30" subjects_at_risk="143"/>
                <counts group_id="E2" events="31" subjects_affected="11" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>sinus congestion</sub_title>
                <counts group_id="E1" events="43" subjects_affected="23" subjects_at_risk="143"/>
                <counts group_id="E2" events="17" subjects_affected="8" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The Caloric Restriction (CR) group fell short of achieving the 25% CR goal specified in the protocol.
The completion rates differed between groups.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>William E. Kraus, Director of Clinical Research, Duke Center for Living</name_or_title>
      <organization>Duke University Medical Center</organization>
      <phone>919-681-6733</phone>
      <email>william.kraus@duke.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

